|
Product Description
|
Recall Class
|
FDA Recall Posting Date
|
Recalling Firm
|
Z-1021-2024 - BD BBL Sensi Disc Cefpodoxime - 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231673 and 231674®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1022-2024 - BD BBL Sensi Disc Ceftaroline - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232231®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1023-2024 - BD BBL Sensi Disc Ceftazidime- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231632®and 231633®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1024-2024 - BD BBL Sensi Disc Ceftriaxone- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231634 and 231635®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1025-2024 - BD BBL Sensi Disc Cefuroxime- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231621®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1026-2024 - BD BBL Sensi Disc Chloramphenicol- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 230733®and 231274®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1027-2024 - BD BBL Sensi Disc Ciprofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231657®and 231658®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1028-2024 - BD BBL Sensi Disc Clarithromycin- 15 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231678®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1029-2024 - BD BBL Sensi Disc Doripenem- 15 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232219®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1030-2024 - BD BBL Sensi Disc Ertapenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232174 and 232175®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|